Dynamic Profiling and Prediction of Antibody Response to SARS-CoV-2 Booster-Inactivated Vaccines by Microsample-Driven Biosensor and Machine Learning

Sumin Bian,Min Shang,Ying Tao,Pengbo Wang,Yankun Xu,Yao Wang,Zhida Shen,Mahamad Sawan

DOI: https://doi.org/10.3390/vaccines12040352

2024-03-26

Vaccines

Abstract:Knowledge of the antibody response to the third dose of inactivated SARS-CoV-2 vaccines is crucial because it is the subject of one of the largest global vaccination programs. This study integrated microsampling with optical biosensors to profile neutralizing antibodies (NAbs) in fifteen vaccinated healthy donors, followed by the application of machine learning to predict antibody response at given timepoints. Over a nine-month duration, microsampling and venipuncture were conducted at seven individual timepoints. A refined iteration of a fiber optic biolayer interferometry (FO-BLI) biosensor was designed, enabling rapid multiplexed biosensing of the NAbs of both wild-type and Omicron SARS-CoV-2 variants in minutes. Findings revealed a strong correlation (Pearson r of 0.919, specificity of 100%) between wild-type variant NAb levels in microsamples and sera. Following the third dose, sera NAb levels of the wild-type variant increased 2.9-fold after seven days and 3.3-fold within a month, subsequently waning and becoming undetectable after three months. Considerable but incomplete evasion of the latest Omicron subvariants from booster vaccine-elicited NAbs was confirmed, although a higher number of binding antibodies (BAbs) was identified by another rapid FO-BLI biosensor in minutes. Significantly, FO-BLI highly correlated with a pseudovirus neutralization assay in identifying neutralizing capacities (Pearson r of 0.983). Additionally, machine learning demonstrated exceptional accuracy in predicting antibody levels, with an error level of <5% for both NAbs and BAbs across multiple timepoints. Microsample-driven biosensing enables individuals to access their results within hours of self-collection, while precise models could guide personalized vaccination strategies. The technology's innate adaptability means it has the potential for effective translation in disease prevention and vaccine development.

immunology,medicine, research & experimental

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to understand and predict the kinetic characteristics of the neutralizing antibody (NAbs) response of individuals to the wild - type and Omicron variants after receiving the third dose of inactivated SARS - CoV - 2 vaccine. Specifically, the study combines the microsample collection technology with the fiber - optic biolayer interferometry (FO - BLI) biosensor and machine - learning methods to achieve the following goals:

1. **Dynamic monitoring of antibody response**: The study aims to dynamically monitor the changes in antibody response by collecting blood samples at multiple time points and using the FO - BLI biosensor to quickly detect and analyze the NAbs levels in the subjects' blood.

2. **Evaluation of immune escape of different variants**: The study also evaluates the neutralizing ability of the NAbs induced by the third dose of vaccine against the latest Omicron sub - variants, especially to explore whether these sub - variants can evade the vaccine - induced immune response.

3. **Prediction of antibody levels**: Using machine - learning algorithms, based on the previously collected data (including physiological parameters and optical measurement data), predict the NAbs levels of individuals at specific time points, thereby providing a basis for personalized vaccination strategies.

4. **Improvement of detection efficiency and accuracy**: By optimizing the design of the biosensor and the detection process, improve the speed and accuracy of NAbs detection, while reducing the dependence on traditional complex detection methods.

5. **Exploration of the application of microsample technology**: The study also verifies the application potential of microsample technology in NAbs detection, especially its non - invasive and high - throughput characteristics, which make it have important public health value during the epidemic.

In summary, this study not only provides an in - depth understanding of the immune response to the inactivated SARS - CoV - 2 vaccine, but also develops an efficient, fast and easy - to - operate detection method, providing new tools and technical support for future vaccine evaluation and disease prevention.